SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCt Priv. Ord Regulatory News (CTPE)

Share Price Information for Ct Priv. Ord (CTPE)

Share Price is delayed by 15 minutes
Get Live Data
500.00    7.50 (1.53%)
Bid:
495.00
Ask:
500.00
Spread: 5.00 (1.01%)
Market Cap: £357.51m
CTPE Live PriceLast checked at - London Stock Exchange

Intraday Ct Priv. Ord Share Chart

Lead Fund Manager Succession

1 Dec 2025 07:00

RNS Number : 5165J
CT Private Equity Trust PLC
01 December 2025
 

To: RNS

From: CT Private Equity Trust PLC ("the Company")

Date: 1 December 2025

 

 

Lead Fund Manager Succession

 

The Board announces that at the conclusion of the Company's Annual General Meeting to be held in May 2026, Hamish Mair will retire from Columbia Threadneedle Investments and step down as the Company's Lead Fund Manager. Upon his retirement, Andrew Carnwath, the Company's Deputy Fund Manager will succeed Hamish as the Company's Lead Fund Manager, ensuring continuity and a smooth handover of responsibilities. Hamish will remain a senior adviser to Columbia Threadneedle Investments available to provide advice to the private equity investment team.

 

Andrew is currently the Company's Deputy Fund Manager. He has worked closely with Hamish Mair for 12 years, and has 17 years of private equity experience. He is a chartered accountant, CFA Charterholder and graduate of The University of Edinburgh.

 

Hamish Mair was instrumental in the creation of the Company in 1999, then known as Martin Currie Capital Return Trust PLC, and has been responsible for its management for the subsequent 26 years. An investor investing £100 at the inception of the Company and re-investing dividends, would now have £1,085, equivalent to a share price total return of 985% or 9.4% per annum. The NAV total return over the same period is 1,233% with an annualised return of 10.2%. The gains accumulated since the start of the Company equate to 12.3x the original investment. By comparison the stock market, as represented by the FTSE All Share index, has provided a total return of 339% with an annualised return of 5.7%. A total gain of approximately 3.4x an investment made in March 1999.

 

The success of the Company under Hamish's leadership was recognised in May 2024 when it was reported that the Company was one of only eight investments trusts or funds available to UK investors, managed by the same lead manager for the previous twenty years, which had outperformed Berkshire Hathaway, managed by Warren Buffet.

 

Richard Gray, the Chairman of the Company noted that, "the Board thanks Hamish Mair for his invaluable contribution to the success of the Company and his tireless enthusiasm for the Private Equity sector and the opportunities that it can provide to investors. The Board looks forward with confidence to continuing the Company's success under the management of Andrew Carnwath".

 

Legal Entity Identifier: 2138009FW98WZFCGRN66

 

For more information, please contact:

 

Hamish Mair (Investment Manager)

0131 573 8314

Scott McEllen (Company Secretary)

0131 573 8372

hamish.mair@columbiathreadneedle.com  / scott.mcellen@columbiathreadneedle.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZMZMVRKGKZM
Date   Source Headline
11th Jun 20261:16 pmRNSDirector/PDMR Shareholding
2nd Jun 20264:38 pmRNSDirector/PDMR Shareholding
1st Jun 202611:01 amRNSTotal Voting Rights
28th May 20264:59 pmRNSAnnual General Meeting and Directorate Change
28th May 202611:21 amRNSQuarterly Results and Dividend Announcement
1st May 202611:39 amRNSTotal Voting Rights
21st Apr 20267:00 amRNSChange in Directorate
21st Apr 20267:00 amRNSAnnual Financial Report
1st Apr 202610:26 amRNSTotal Voting Rights
27th Mar 20267:00 amRNSPreliminary Results and Dividend Announcement
19th Mar 20267:00 amRNS-RInvestor Presentation
2nd Mar 20263:04 pmRNSTotal Voting Rights
3rd Feb 202610:37 amRNSTotal Voting Rights
8th Jan 202611:48 amRNSDirector/PDMR Shareholding
2nd Jan 202610:28 amRNSTotal Voting Rights
22nd Dec 20257:00 amRNSDirectorate Change
22nd Dec 20257:00 amRNSDirectorate Change
10th Dec 20257:00 amRNS-RKepler Trust Intelligence: New Research
1st Dec 202511:10 amRNSTotal Voting Rights
1st Dec 20257:00 amRNSLead Fund Manager Succession
27th Nov 20257:00 amRNSThird Quarter Results and Dividend Declaration
24th Nov 20259:37 amRNS-RInvestor Presentation
6th Nov 20251:44 pmRNS-RProfessional Investor Presentation
3rd Nov 20259:17 amRNSTotal Voting Rights
1st Oct 202510:19 amRNSTotal Voting Rights
2nd Sep 20252:56 pmRNSTotal Voting Rights
28th Aug 202512:50 pmRNS-RQuotedData's In The HotSeat Special
28th Aug 20257:00 amRNSInterim Results and Dividend Announcement
20th Aug 20257:00 amRNS-RInvestor Presentation
1st Aug 202510:29 amRNSTotal Voting Rights
1st Jul 20259:55 amRNSTotal Voting Rights
2nd Jun 202510:08 amRNSTotal Voting Rights
29th May 20253:17 pmRNSResult of AGM
29th May 20251:00 pmRNSQuarterly Results And Dividend Announcement
1st May 202510:27 amRNSTotal Voting Rights
15th Apr 20257:00 amRNSAnnual Financial Report
9th Apr 20254:07 pmRNSDirector/PDMR Shareholding
3rd Apr 20257:00 amRNS-RKepler Trust Intelligence: New Research
1st Apr 202511:06 amRNSTotal Voting Rights
28th Mar 20257:00 amRNSPreliminary results and Dividend Announcement
25th Mar 20252:44 pmRNS-RInvestor Presentation
3rd Mar 20251:19 pmRNSTotal Voting Rights
3rd Feb 20251:14 pmRNSTotal Voting Rights
2nd Jan 202511:19 amRNSTotal Voting Rights
2nd Dec 20249:30 amRNSDirector/PDMR Shareholding
2nd Dec 20249:25 amRNSTotal Voting Rights
29th Nov 202412:26 pmRNSDirector/PDMR Shareholding
28th Nov 20247:00 amRNSQuarterly Results and Dividend Announcement
1st Nov 20249:16 amRNSTotal Voting Rights
1st Oct 202411:09 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.